Surgical treatment of chronic inflammatory bowel disease in children

S Barrena1, L Martínez, F Hernandez

  • 1Department of Pediatric Surgery, Hospital Universitario La Paz, Madrid, Spain.

Insights

Pediatric surgery for inflammatory bowel disease (IBD) can significantly improve quality of life for Crohn's disease patients, while ulcerative colitis patients often achieve good outcomes after restorative proctocolectomy and ileoanal anastomosis.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Inflammatory Bowel Disease Research

Background:

  • Surgery is increasingly common for pediatric chronic inflammatory bowel disease (IBD).
  • Assessing surgical outcomes is crucial for effective preoperative patient and family counseling.

Purpose of the Study:

  • To evaluate the outcomes of surgical interventions in children with IBD.
  • To provide data for informed preoperative counseling regarding surgical results, complications, and long-term functional status.

Main Methods:

  • Retrospective review of pediatric IBD patients treated between 1992 and 2009.
  • Recording of operations, complications, and functional outcomes.
  • Long-term assessment of continence (Koivusalo score) and quality of life using standardized questionnaires for patients with preserved rectal defecation.

Main Results:

  • Crohn's disease (CD) patients undergoing bowel resection showed significant improvements in nutritional status, growth, and quality of life.
  • Ulcerative colitis (UC) patients undergoing restorative proctocolectomy and ileoanal anastomosis (RPCIA) experienced frequent complications (40%) but reported good quality of life, daytime continence, and functional recovery within a year.
  • Permanent ileostomy was necessary for a subset of UC patients (17%).

Conclusions:

  • Surgical management of IBD in children can lead to life-changing improvements for CD patients.
  • RPCIA offers a reasonably good quality of life for UC patients after the initial postoperative year.
  • Pediatric surgeons must be equipped to provide comprehensive preoperative counseling based on these surgical outcomes.

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...